Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.
Eguchi T, Kadota K, Chaft J, Evans B, Kidd J, Tan KS, Dycoco J, Kolquist K, Davis T, Hamilton SA, Yager K, Jones JT, Travis WD, Jones DR, Hartman AR, Adusumilli PS.
Eguchi T, et al. Among authors: adusumilli ps.
Oncotarget. 2016 Jun 7;7(23):35241-56. doi: 10.18632/oncotarget.9129.
Oncotarget. 2016.
PMID: 27153551
Free PMC article.